Skip to content
Morgan & Mendel Genomics | Genetic Testing
  • Mission/Purpose
    • What are functional genomic tests?
    • Our Products
  • About Morgan and Mendel Genomics
    • Scientific and Business Advisory Board
    • Our Team
  • Where to Learn More
    • Publications
    • Patents
    • Grants
  • Contact Us

Grants

NCI STTR grants

1 R41 CA217383-01A1, Robust Predictor of Breast Cancer Risk (09/01/2017-08/31/2019)

2 R42 CA217383-02A1, Robust Predictor of Breast Cancer Risk (09/01/2020-08/31/2023)

1 R41 CA232867-01A1, Robust Predictor of Colon Cancer Risk (09/13/2018-08/31/2020)

2 R42 CA232867-02A1, Robust Predictor of Colon Cancer Risk (08/15/2022-07/31/2024)

AFWERX SBIR grant

Precision genomics for United States Air Force personnel using Cancer Risk B and Cancer Risk C – SBIR
(Phase I 11/3/2021 to 2/7/2022, Phase II 7/11/2022 to 10/31/2023)

Copyright 2021
Contact Morgan & Mendel: 770.656.6484
Iconic One Theme | Powered by Wordpress